Feel clear about your Ocrevus infusion 

Pim, UK


Living with MS since 2021


On Ocrevus since 2021

Pim, UK


Living with MS since 2021


On Ocrevus since 2021

Feel clear about your Ocrevus infusion 

You and your MS team have decided that you will receive your treatment with Ocrevus using an intravenous (IV) infusion (drip) procedure.1


Ocrevus will be given to you by a doctor or nurse who’s experienced in using this treatment, and they’ll monitor you closely throughout your infusion and for at least 1 hour afterwards. Your treatment will most likely take place in hospital.1


Ocrevus treatment begins with one dose split into two infusions separated by 2 weeks, with subsequent doses given as a single infusion.


Icon 300 mg + 300 mg

Your first dose of Ocrevus will be split into 2 infusions of 300 mg, given 14 days apart. Although the length of treatment time does vary from patient to patient, generally each Ocrevus infusion will last about 2.5 hours.1


Icon 600 mg

After that you'll be given a single infusion (600 mg) every 6 months.1 Each of these may last between 2 to 3.5 hours, depending on how you tolerate the first dose.1 Don’t worry if yours takes longer, as everyone’s treatment experience is different.


Calendar icon

The amount of time you stay on treatment with Ocrevus will depend on two things: how well Ocrevus works to slow the progression of your MS, and how well you tolerate treatment side effects. These two factors will help you and your medical team decide how long you’ll take Ocrevus for.


What happens on infusion day?

You’ll need to spend up to 6 hours in hospital on each infusion day. While you’re having your infusion, you will be sitting up, so you can read, play games, watch films, listen to music or simply relax.


A nurse will run through a checklist to ensure you're OK to have your infusion — for example they'll check that you don't have any infections such as flu and you may be asked to take some additional tests. You may also have a cannula put into a vein in your arm; this is the thin tube that your infusion of Ocrevus will travel through to get into your bloodstream to travel to where it needs to work.


Before your Ocrevus infusion, you’ll be given other medications to help prevent or reduce possible side effects such as headache, nausea and itching.1


These pre-medications will include a steroid and an antihistamine, and may also include a drug that reduces fever (an antipyretic, like paracetamol).1 These will be given to you before every treatment of Ocrevus.


Your first infusion of Ocrevus will be a 300 mg half-dose, given via a drip into a vein in your arm. This is likely to take up to 2.5 hours.1 The infusion may be given at a slower rate at first, then gradually sped up. You’ll be closely monitored by your doctor or nurse throughout,1 so just try to relax with a book, movie, music or game.


After your infusion, your doctor or nurse will continue to monitor you for at least 1 hour, to make sure you’re OK to go home.1


Your cannula may be kept in your arm during this time, so an IV flush can be carried out to clean the tube.


If you get a reaction during your infusion or within 24 hours (for example, itchy skin, a rash, a headache, or shortness of breath), tell your MS team straight away.1


Your second infusion with Ocrevus will take place 2 weeks after your first infusion, and will also be a 300 mg half-dose, probably taking the same amount of time.1 You will also have the same pre-medications as your first infusion.


6 months after your second infusion, and every 6 months in future, you’ll return to hospital for a full dose (600 mg) infusion of Ocrevus. This will be a very similar experience, including the pre-medication process. Once you are being given a full dose of Ocrevus, the infusion itself can take between 2 to 3.5 hours depending on how well you tolerate the infusion.1


If you miss an infusion of Ocrevus, talk to your MS team to arrange to have it as soon as possible. Don’t wait until your next planned infusion.1

Watch the video below to hear about what you might expect for your infusion

PIM

“Try not to worry too much, the nurses will take care of you on the day” 

Pim


who has relapsing remitting MS (RRMS), on Ocrevus IV infusion

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. Please report suspected side effects to the MHRA through the Yellow Card scheme, via the Yellow card website www.mhra.gov.uk/yellowcard, or the free Yellow Card app available in the Apple App Store or Google Play Store. You should also report side effects to Roche Products Ltd. by emailing the Roche Drug Safety Centre at welwyn.uk_dsc@roche.com or calling +44 (0) 1707 367554. By reporting side effects you can help provide more information on the safety of this medicine.

References:

  1. Ocrevus. Patient Information Leaflet. Ocrevus 300 mg Concentrate for Solution for Infusion Ocrelizumab. Roche Products Limited.